Home NDC 60635-133 Varithena
Product NDC 60635-133
11-digit product format 606350133
Labeler code 60635
Product ID 60635-133_d9bdfa34-448a-4adf-a25f-f49453c7cc96
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name polidocanol
Dosage form KIT
Labeler Boston Scientific Corporation
Application NDA205098
Marketing category NDA
Marketing start 2013-11-25
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 2 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Product NDC Package NDC Code Status Reporting period Archive Snapshot Source SHA-256 2022-08-30 03:57 UTC · source 2022-08-29 excluded product product 60635-133 I Inactivated by FDA excluded / ndc_excluded.zip fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 60635-133 60635-133-01 I Inactivated by FDA excluded / ndc_excluded.zip fb8cb913e6d1…eb8c232b6be0…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N205098-001 VARITHENA POLIDOCANOL 180MG/18ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2013-11-25 N205098-002 VARITHENA POLIDOCANOL 77.5MG/7.75ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2017-12-21
Orange Book patents# Current patent rows page 1 of 1 · 2 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N205098-001 7814943 2027-11-19 U-1461 Drug product N205098-001 9480652 2032-05-12 Drug product 2016-11-30
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 88 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 N205098-001 VARITHENA 180MG/18ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2013-11-25 c2088c7a36db…2026-10-15 13:18:30 2026-09 N205098-002 VARITHENA 77.5MG/7.75ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2017-12-21 c2088c7a36db…2026-09-14 22:38:34 2026-08 N205098-001 VARITHENA 180MG/18ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2013-11-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 N205098-002 VARITHENA 77.5MG/7.75ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2017-12-21 84e616aacf4f…2026-08-18 06:07:40 2026-07 N205098-001 VARITHENA 180MG/18ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2013-11-25 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N205098-002 VARITHENA 77.5MG/7.75ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2017-12-21 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N205098-001 VARITHENA 180MG/18ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2013-11-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205098-002 VARITHENA 77.5MG/7.75ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2017-12-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205098-001 VARITHENA 180MG/18ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2013-11-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205098-002 VARITHENA 77.5MG/7.75ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2017-12-21 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N205098-001 VARITHENA 180MG/18ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2013-11-25 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205098-002 VARITHENA 77.5MG/7.75ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2017-12-21 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205098-001 VARITHENA 180MG/18ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2013-11-25 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205098-002 VARITHENA 77.5MG/7.75ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2017-12-21 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205098-001 VARITHENA 180MG/18ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2013-11-25 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205098-002 VARITHENA 77.5MG/7.75ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2017-12-21 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205098-001 VARITHENA 180MG/18ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2013-11-25 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205098-002 VARITHENA 77.5MG/7.75ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2017-12-21 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205098-001 VARITHENA 180MG/18ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2013-11-25 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205098-002 VARITHENA 77.5MG/7.75ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2017-12-21 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N205098-001 VARITHENA 180MG/18ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2013-11-25 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N205098-002 VARITHENA 77.5MG/7.75ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2017-12-21 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N205098-001 VARITHENA 180MG/18ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2013-11-25 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N205098-002 VARITHENA 77.5MG/7.75ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2017-12-21 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N205098-001 VARITHENA 180MG/18ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2013-11-25 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N205098-002 VARITHENA 77.5MG/7.75ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2017-12-21 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N205098-001 VARITHENA 180MG/18ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2013-11-25 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N205098-002 VARITHENA 77.5MG/7.75ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2017-12-21 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N205098-001 VARITHENA 180MG/18ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2013-11-25 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N205098-002 VARITHENA 77.5MG/7.75ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2017-12-21 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N205098-001 VARITHENA 180MG/18ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2013-11-25 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N205098-002 VARITHENA 77.5MG/7.75ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2017-12-21 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N205098-001 VARITHENA 180MG/18ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2013-11-25 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N205098-002 VARITHENA 77.5MG/7.75ML (10MG/ML) SOLUTION / INTRAVENOUS RLD 2017-12-21 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N205098-001 VARITHENA 180MG/18ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2013-11-25 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N205098-002 VARITHENA 77.5MG/7.75ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-12-21 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N205098-001 VARITHENA 180MG/18ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2013-11-25 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N205098-002 VARITHENA 77.5MG/7.75ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-12-21 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N205098-001 VARITHENA 180MG/18ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2013-11-25 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N205098-002 VARITHENA 77.5MG/7.75ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2017-12-21 4b0b4de00fa7…
Observed Orange Book patent history# Patent history page 1 of 6 · 230 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-10-15 13:18:30 2026-09 N205098-001 7814943 2027-11-19 U-1461 Drug product c2088c7a36db…2026-10-15 13:18:30 2026-09 N205098-001 9480652 2032-05-12 Drug product 2016-11-30 c2088c7a36db…2026-09-14 22:38:34 2026-08 N205098-001 7814943 2027-11-19 U-1461 Drug product 84e616aacf4f…2026-09-14 22:38:34 2026-08 N205098-001 9480652 2032-05-12 Drug product 2016-11-30 84e616aacf4f…2026-08-18 06:07:40 2026-07 N205098-001 7814943 2027-11-19 U-1461 Drug product caaa826d4ba7…2026-08-18 06:07:40 2026-07 N205098-001 9480652 2032-05-12 Drug product 2016-11-30 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N205098-001 7814943 2027-11-19 U-1461 Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205098-001 9480652 2032-05-12 Drug product 2016-11-30 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205098-001 7814943 2027-11-19 U-1461 Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205098-001 9480652 2032-05-12 Drug product 2016-11-30 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N205098-001 7814943 2027-11-19 U-1461 Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205098-001 9480652 2032-05-12 Drug product 2016-11-30 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205098-001 7814943 2027-11-19 U-1461 Drug product fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205098-001 9480652 2032-05-12 Drug product 2016-11-30 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205098-001 7814943 2027-11-19 U-1461 Drug product b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205098-001 9480652 2032-05-12 Drug product 2016-11-30 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205098-001 8122917 2024-09-09 Drug product 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205098-001 7731986 2024-11-17 U-1463 Drug substance, Drug product 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205098-001 7814943 2027-11-19 U-1461 Drug product 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205098-001 9480652 2032-05-12 Drug product 2016-11-30 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205098-001 8122917 2024-09-09 Drug product 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205098-001 7731986 2024-11-17 U-1463 Drug substance, Drug product 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205098-001 7814943 2027-11-19 U-1461 Drug product 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205098-001 9480652 2032-05-12 Drug product 2016-11-30 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N205098-001 8122917 2024-09-09 Drug product 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N205098-001 7731986 2024-11-17 U-1463 Drug substance, Drug product 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N205098-001 7814943 2027-11-19 U-1461 Drug product 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N205098-001 9480652 2032-05-12 Drug product 2016-11-30 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N205098-001 8122917 2024-09-09 Drug product d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N205098-001 7731986 2024-11-17 U-1463 Drug substance, Drug product d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N205098-001 7814943 2027-11-19 U-1461 Drug product d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N205098-001 9480652 2032-05-12 Drug product 2016-11-30 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N205098-001 8122917 2024-09-09 Drug product d06236e962d9…2024-10-29 15:01 UTC 2024-10 N205098-001 7731986 2024-11-17 U-1463 Drug substance, Drug product d06236e962d9…2024-10-29 15:01 UTC 2024-10 N205098-001 7814943 2027-11-19 U-1461 Drug product d06236e962d9…2024-10-29 15:01 UTC 2024-10 N205098-001 9480652 2032-05-12 Drug product 2016-11-30 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N205098-001 8122917 2024-09-09 Drug product 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N205098-001 7731986 2024-11-17 U-1463 Drug substance, Drug product 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N205098-001 7814943 2027-11-19 U-1461 Drug product 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N205098-001 9480652 2032-05-12 Drug product 2016-11-30 79d66fd596c7…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Varithena
Listing expiration 2027-12-31 DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# Effective, Related label table Effective Related label 2022-12-21 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2022-12-21 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2022-12-21 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2022-12-21 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2022-12-21 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2022-07-29 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2022-07-29 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2022-07-29 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2022-07-29 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2022-07-29 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2020-07-22 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2020-07-22 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2020-07-22 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2020-07-22 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2020-07-22 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2020-03-12 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2020-03-12 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2020-03-12 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2020-03-12 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2020-03-12 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2020-01-31 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2020-01-31 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2020-01-31 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2020-01-31 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013 2020-01-31 These highlights do not include all the information needed to use VARITHENA® safely and effectively. See Full Prescribing Information for VARITHENA. VARITHENA (polidocanol injectable foam), for intravenous use Initial U.S. Approval: 2013
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 60635-018-01 Varithena 18 mL in 1 CANISTER INJECTABLE FOAM 18 mL 10 mg in 1mL 17 60635-133-01 Varithena 1 in 1 CARTON KIT 1 17 60635-133-01 Varithena 1 in 1 PACKAGE KIT 1 17
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded POLIDOCANOL ACTIVE INGREDIENT 0AWH8BFG9A VARITHENA (POLIDOCANOL) KIT [BIOCOMPATIBLES, INC.] 5 POLIDOCANOL ACTIVE MOIETY 0AWH8BFG9A VARITHENA (POLIDOCANOL) KIT [BIOCOMPATIBLES, INC.] 5 ALCOHOL INACTIVE INGREDIENT 3K9958V90M VARITHENA (POLIDOCANOL) KIT [BIOCOMPATIBLES, INC.] 5 CARBON DIOXIDE INACTIVE INGREDIENT 142M471B3J VARITHENA (POLIDOCANOL) KIT [BIOCOMPATIBLES, INC.] 5 OXYGEN INACTIVE INGREDIENT S88TT14065 VARITHENA (POLIDOCANOL) KIT [BIOCOMPATIBLES, INC.] 5 POTASSIUM PHOSPHATE, MONOBASIC INACTIVE INGREDIENT 4J9FJ0HL51 VARITHENA (POLIDOCANOL) KIT [BIOCOMPATIBLES, INC.] 5 SODIUM PHOSPHATE, DIBASIC, DIHYDRATE INACTIVE INGREDIENT 94255I6E2T VARITHENA (POLIDOCANOL) KIT [BIOCOMPATIBLES, INC.] 5 WATER INACTIVE INGREDIENT 059QF0KO0R VARITHENA (POLIDOCANOL) KIT [BIOCOMPATIBLES, INC.] 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 60635-133 VARITHENA (POLIDOCANOL) KIT [BIOCOMPATIBLES, INC.] 14 Current NDC, Legacy NDC, 3 package rows 20241012_dfd6b4a0-b0dc-11e2-9e96-0800200c9a66.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 60635-018-01 60635001801 18 mL in 1 CANISTER 18 ml Historical 60635-133-01 60635013301 1 CARTON in 1 PACKAGE (60635-133-01) / 1 POUCH in 1 CARTON / 1 KIT in 1 POUCH * 18 mL in 1 CANISTER (60635-018-01) * 303 mL in 1 CANISTER 1 carton 2016-06-22 0000-00-00 No No Current